Cargando…

P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Weisel, K., Mateos, M.-V., Vincent, L., Martin, T., Berdeja, J. G., Jakubowiak, A., Jagannath, S., Lin, Y., Thilakarathne, P., Ghilotti, F., Diels, J., Haefliger, B., Hague, C., Gonzalez, A., Schecter, J. M., Gries, K. S., Strulev, V., Nesheiwat, T., Pacaud, L., Einsele, H., Moreau, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429348/
http://dx.doi.org/10.1097/01.HS9.0000846752.50612.48
_version_ 1784779412565131264
author Weisel, K.
Mateos, M.-V.
Vincent, L.
Martin, T.
Berdeja, J. G.
Jakubowiak, A.
Jagannath, S.
Lin, Y.
Thilakarathne, P.
Ghilotti, F.
Diels, J.
Haefliger, B.
Hague, C.
Gonzalez, A.
Schecter, J. M.
Gries, K. S.
Strulev, V.
Nesheiwat, T.
Pacaud, L.
Einsele, H.
Moreau, P.
author_facet Weisel, K.
Mateos, M.-V.
Vincent, L.
Martin, T.
Berdeja, J. G.
Jakubowiak, A.
Jagannath, S.
Lin, Y.
Thilakarathne, P.
Ghilotti, F.
Diels, J.
Haefliger, B.
Hague, C.
Gonzalez, A.
Schecter, J. M.
Gries, K. S.
Strulev, V.
Nesheiwat, T.
Pacaud, L.
Einsele, H.
Moreau, P.
author_sort Weisel, K.
collection PubMed
description
format Online
Article
Text
id pubmed-9429348
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94293482022-08-31 P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA Weisel, K. Mateos, M.-V. Vincent, L. Martin, T. Berdeja, J. G. Jakubowiak, A. Jagannath, S. Lin, Y. Thilakarathne, P. Ghilotti, F. Diels, J. Haefliger, B. Hague, C. Gonzalez, A. Schecter, J. M. Gries, K. S. Strulev, V. Nesheiwat, T. Pacaud, L. Einsele, H. Moreau, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429348/ http://dx.doi.org/10.1097/01.HS9.0000846752.50612.48 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Weisel, K.
Mateos, M.-V.
Vincent, L.
Martin, T.
Berdeja, J. G.
Jakubowiak, A.
Jagannath, S.
Lin, Y.
Thilakarathne, P.
Ghilotti, F.
Diels, J.
Haefliger, B.
Hague, C.
Gonzalez, A.
Schecter, J. M.
Gries, K. S.
Strulev, V.
Nesheiwat, T.
Pacaud, L.
Einsele, H.
Moreau, P.
P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
title P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
title_full P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
title_fullStr P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
title_full_unstemmed P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
title_short P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
title_sort p971: adjusted comparison of patient reported outcomes from cartitude-1 and locommotion comparing ciltacabtagene autoleucel versus real world clinical practice in triple-class exposed multiple myeloma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429348/
http://dx.doi.org/10.1097/01.HS9.0000846752.50612.48
work_keys_str_mv AT weiselk p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT mateosmv p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT vincentl p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT martint p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT berdejajg p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT jakubowiaka p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT jagannaths p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT liny p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT thilakarathnep p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT ghilottif p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT dielsj p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT haefligerb p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT haguec p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT gonzaleza p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT schecterjm p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT griesks p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT strulevv p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT nesheiwatt p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT pacaudl p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT einseleh p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma
AT moreaup p971adjustedcomparisonofpatientreportedoutcomesfromcartitude1andlocommotioncomparingciltacabtageneautoleucelversusrealworldclinicalpracticeintripleclassexposedmultiplemyeloma